statements

Triochem Products Ltd.

BSE: 512101

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

-+0.0 (+0.00%)

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Triochem Products Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	12.36	30.80	33.74	30.68	23.11	18.06	34.99	12.35	20.03	13.94	8.82	-	-	-	-	-
Cost of Operating Revenue	9.03	27.51	31.28	28.49	20.86	15.45	29.02	8.64	13.77	12.75	6.41	0.10	0.09	0.13	0.04	0.03
Gross Profit	3.33	3.29	2.47	2.19	2.26	2.61	5.97	3.72	6.26	1.19	2.41	-0.10	-0.09	-0.13	-0.04	-0.03
Gross Margin	27.0	10.7	7.3	7.1	9.8	14.5	17.1	30.1	31.2	8.6	27.3	-	-	-	-	-
Total Operating Expenses	10.10	28.48	32.72	29.79	22.43	17.35	31.45	10.92	15.72	14.54	7.60	1.45	1.15	1.30	1.43	1.10
Operating Profit	2.26	2.32	1.02	0.88	0.68	0.71	3.54	1.44	4.32	-0.61	1.22	-1.45	-1.15	-1.30	-1.43	-1.10
Operating Margin	18.3	7.5	3.0	2.9	3.0	3.9	10.1	11.6	21.5	-4.3	13.8	-	-	-	-	-
Financing Income/(Expense) - Net	0.00	-1.37	-0.30	-0.41	-0.19	-0.06	-0.38	-0.45	-0.23	-0.11	-0.02	-	-	-	0.17	-0.08
Profit before Taxes	2.33	1.21	0.79	0.55	0.52	0.81	3.57	1.04	4.55	-0.58	1.76	-1.17	-1.33	-0.25	10.52	10.79
Income Taxes	0.76	0.41	0.26	0.13	0.17	0.23	1.01	0.30	1.15	-0.13	0.44	-0.28	-0.32	0.15	2.55	2.70
Profit after Tax	1.57	0.80	0.53	0.42	0.34	0.58	2.56	0.74	3.40	-0.45	1.32	-0.89	-1.01	-0.40	7.97	8.10
PAT Margin	12.7	2.6	1.6	1.4	1.5	3.2	7.3	6.0	17.0	-3.2	15.0	-	-	-	-	-
EPS - Basic - ex Extraordinary Items	64.22	32.73	21.46	16.98	13.94	23.51	104.29	30.33	138.89	-18.24	53.99	-36.13	-41.36	-16.33	325.34	330.46
EPS - Diluted - ex Extraordinary Items	64.22	32.73	21.46	16.98	13.94	23.51	104.29	30.33	138.89	-18.24	53.99	-36.13	-41.36	-16.33	325.34	330.46
EBIT	2.26	2.32	1.02	0.88	0.68	0.71	3.54	1.44	4.32	-0.61	1.22	-1.45	-1.15	-1.30	-1.43	-1.10
EBITDA	2.42	2.65	1.33	1.21	0.95	0.98	3.79	1.64	4.48	-0.47	1.34	-1.35	-1.06	-1.22	-1.39	-1.07
EBITDA Margin	19.6	8.6	4.0	3.9	4.1	5.4	10.8	13.3	22.4	-3.4	15.2	-	-	-	-	-

Balance Sheet

Abridged

Understanding Balance Sheet

Triochem Products Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	7.92	18.36	8.46	6.01	1.19	8.16	9.95	13.84	15.37	11.00	12.04	1.28	2.73	2.52	12.99
Long-Term Investments	0.12	0.12	0.12	0.12	3.87	0.17	0.17	0.16	0.15	0.15	0.15	9.56	11.23	10.78	7.89
Property Plant & Equipment - Net	2.48	2.47	2.26	2.09	1.79	1.54	1.33	1.14	1.01	0.90	0.80	0.70	0.61	0.54	-
Total Non-Current Assets	2.69	2.69	2.47	2.47	5.85	2.12	1.85	1.31	1.25	1.10	1.29	10.55	12.16	11.37	7.89
Total Assets	10.61	21.06	10.93	8.48	7.03	10.28	11.80	15.15	16.62	12.10	13.33	11.84	14.89	13.89	20.88
Total Current Liabilities	6.97	17.11	5.96	3.70	1.91	4.64	3.64	6.26	4.35	0.39	0.21	0.24	0.27	0.22	0.03
Total Non-Current Liabilities	0.83	0.33	0.83	0.23	0.22	0.16	0.13	0.12	0.09	-	0.07	-	-	-	0.20
Total Liabilities	7.80	17.44	6.79	3.93	2.13	4.80	3.77	6.38	4.44	0.39	0.28	0.24	0.27	0.22	0.23
Total Shareholders' Equity	2.81	3.61	4.14	4.55	4.90	5.48	8.03	8.78	12.18	11.71	13.05	11.60	14.62	13.67	20.65
Total Equity	2.81	3.61	4.14	4.55	4.90	5.48	8.03	8.78	12.18	11.71	13.05	11.60	14.62	13.67	20.65
Total Liabilities & Equity	10.61	21.06	10.93	8.48	7.03	10.28	11.80	15.15	16.62	12.10	13.33	11.84	14.89	13.89	20.88

Cash Flow

Abridged

Understanding Cash Flow Statement

Triochem Products Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1.83	1.11	1.10	0.23	0.76	0.90	3.14	0.39	3.70	-0.86	1.36	-1.36	-1.59	-0.41	-2.79
Working Capital - Increase/(Decrease)	-6.57	-10.53	10.66	1.71	5.86	-7.41	-2.02	-4.57	-0.07	11.03	2.27	-0.06	-1.97	0.77	0.09
Net CF from Operating Activities	-4.74	-9.42	11.76	1.93	6.62	-6.51	1.12	-4.17	3.63	10.17	3.64	-1.42	-3.56	0.37	-2.70
Capital Expenditures - Net	1.21	0.41	0.10	0.10	0.11	0.03	0.03	0.01	0.03	0.02	0.03	-	-	-	-11.72
Net CF from Investing Activities	-1.21	-0.41	-0.10	-0.10	-3.72	3.69	-0.03	-0.01	-0.03	-0.02	-0.03	-9.43	3.14	0.00	13.52
Debt - LT & ST - Issuance/(Retirement) - Total	5.30	9.91	-11.38	-1.28	-3.50	2.86	-0.57	3.51	-3.29	-2.50	-	-	-	-	-
Net Cash Flow from Financing Activities	5.30	9.91	-11.38	-1.28	-3.50	2.86	-0.57	3.51	-3.29	-2.50	-	-	-	-	-
Free Cash Flow to Equity	-0.65	0.07	0.28	0.56	3.01	-3.68	0.52	-0.67	0.30	7.64	3.61	-1.42	-3.56	-	9.02
Free Operating CF net dividend	-5.95	-9.83	11.66	1.83	6.51	-6.53	1.09	-4.18	3.60	10.15	3.61	-1.42	-3.56	0.37	-2.70
Free Operating CF	-5.95	-9.83	11.66	1.83	6.51	-6.53	1.09	-4.18	3.60	10.15	3.61	-1.42	-3.56	0.37	-2.70

Business Segment Analysis

Triochem Products Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Triochem Products Ltd.

Regional Segment Analysis

FY End:

Mar 12

Triochem Products Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Within India (96.5%)₹ 11.93 CrOutside India (3.5%)₹ 0.43 Cr

Assets

Within India (100.0%)₹ 10.61 Cr

Historical Segment Analysis

Track how Triochem Products Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Sales

Assets

Business

Regional

Business

We don't have enough data to show the Capex for Triochem Products Ltd..

Frequently Asked Questions

What is the revenue of Triochem Products Ltd.?

The latest trailing twelve month revenue of Triochem Products Ltd. is ₹ 0.17 Cr. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Triochem Products Ltd.?

The latest trailing twelve month net profit (PAT) of Triochem Products Ltd. is ₹ 8.10 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Triochem Products Ltd.?

The trailing twelve month EBITDA of Triochem Products Ltd. is approximately ₹ -0.94 Cr (based on an operating margin of -565.46%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Triochem Products Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Triochem Products Ltd. is 330.46. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Triochem Products Ltd.?

The debt-to-equity ratio of Triochem Products Ltd. stands at 0.00. The interest coverage ratio is -18.08x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Triochem Products Ltd.?

The book value per share of Triochem Products Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Triochem Products Ltd.?

The trailing twelve month operating cash flow of Triochem Products Ltd. is ₹ -2.70 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Triochem Products Ltd. report consolidated or standalone financials?

Triochem Products Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.